G. Walmsley Graham - 13 Dec 2024 Form 4/A - Amendment Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
13 May 2025, 19:14:52 UTC
Original report date
17 Dec 2024
Prior SEC filing
18 Jun 2024
Next SEC filing
07 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Graham Walmsley

Key filing fact

G. Walmsley Graham filed Form 4/A - Amendment for Olema Pharmaceuticals, Inc. (OLMA) on 13 May 2025.

Key facts

  • This page summarizes G. Walmsley Graham's Form 4/A - Amendment filing for Olema Pharmaceuticals, Inc. (OLMA).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 May 2025, 19:14.

Change

  • Previous filing in this sequence was filed on 18 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001777517 Primary reporting owner

Graham G. Walmsley

Relationship
Director
Address
ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO
Signature
/s/ Graham Walmsley
Signature date
13 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OLMA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,800,000
Date
13 Dec 2024
Ownership
See note
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These securities are held by Logos Global Master Fund LP ("Logos Master Fund"). This holding was inadvertently omitted from the Form 4 filed by the reporting person on December 17, 2024. Logos Master Fund did not participate in the transactions reported in that Form 4. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .